Table 3.

LXR agonist T0901317 improves renal injury in db/db mice (n = 6, $\overline{x}$ ± s).

Group	Scr (μmol·L−1)	Microalbuminuria (mg/L)
Ctrl	25.17 ± 2.86	0.65 ± 0.027
DN	45.50 ± 1.88*	1.24 ± 0.11*
Ad-ctrl+DN	44.83 ± 3.06*	1.27 ± 0.02*
T0901317+DN	30.67 ± 2.16*#	0.72 ± 0.02*#
Ad-TMshRNA+DN	65.50 ± 2.90*#	1.88 ± 0.03*#

^*p < 0.05, vs. Ctrl group;

^#p < 0.05 vs. DN group and Ad-ctrl+DN group.